Loading
A phase 1 trial of ITIL-168 run by Instil Bio, withdrawn before enrolling.
ITIL-168 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT05393635 by Instil Bio, started 2022-08. Conditions recorded: Cervical Cancer, Head and Neck Squamous Cell Carcinoma and Non-small Cell Lung Cancer. Interventions recorded: ITIL-168.
Shares ITIL-168, Instil Bio and the tag pipeline.
Shares Instil Bio, Non-small-cell lung cancer and the tag pipeline.
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
Shares Cervical cancer, Head and neck squamous cell carcinoma and the tag pipeline.
Shares Cervical cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
Shares Cervical cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/